Reversing of multidrug resistance breast cancer by co-delivery of P-gp siRNA and doxorubicin via folic acid-modified core-shell nanomicelles
Yang WuResearch Center of Clinical Oncology, Jiangsu Cancer Hospital, Nanjing 210009, PR ChinaYu ZhangState Key Laboratory of Bioelectronics, Jiangsu Key Laboratory for Biomaterials and Devices, School of Biological Science and Medical Engineering, Southeast University, Nanjing 210009, PR ChinaWei ZhangState Key Laboratory of Bioelectronics, Jiangsu Key Laboratory for Biomaterials and Devices, School of Biological Science and Medical Engineering, Southeast University, Nanjing 210009, PR ChinaChunlong SunSchool of Chemistry and Chemical Engineering, Southeast University, Nanjing 210096, PR ChinaJianzhong WuResearch Center of Clinical Oncology, Jiangsu Cancer Hospital, Nanjing 210009, PR ChinaJinhai TangDepartment of General Surgery, Jiangsu Cancer Hospital, Nanjing 210009, PR China. Electronic address: [email protected]
2015en
ABI
Аннотация
Аннотация отсутствует.
Идентификаторы
Цитирования и источники
Цитирований: 2Использованных источников: 0